NEW YORK (GenomeWeb News) – ZenBio today said that it has licensed rights from Harvard University to become a commercial source for the murine 3T3-L1 cell line for use in metabolic research.
The cell line is derived from 3T3 cells and is used in research on adipose tissue, making it popular for metabolic disease research studies, said the Research Triangle park, NC-based firm. It added that the cell line is recognized as a "very well-characterized, consistent in vitro system, and has served as the basis for a wide range of published studies."
ZenBio will offer the cell lines in low-passage cryopreserved and cultured forms, and it will also offer contract research services tailored to the 3T3-L1 in vitro system. Those services will include assay development, compound screening, conditioned media delivery, gene-expression profiling and further 3T3-L1 characterization. ZenBio also plans to offer metabolic research kits to measure various outputs from 3T3-L1 assays.
Terms of the license were not disclosed.